Type-II Variation: Waive in-vivo study by providing in-vitro data? [Study As­sess­ment]

posted by qualityassurance – 2024-07-02 13:29 (302 d 04:31 ago) – Posting: # 24054
Views: 2,288

Dear Helmut,

Thank you for the response.

Is it possible to waive in-vivo study if we achieve similar in-vitro dissolution profile in multimedia between test products (BE batch vs new formulation) having different particle size?

Regards,
QA

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
18 visitors (0 registered, 18 guests [including 10 identified bots]).
Forum time: 18:01 CEST (Europe/Vienna)

Garbage in, garbage out.
It’s very very simple.    Anders Fuglsang

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5